BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210120
DTEND;VALUE=DATE:20210122
DTSTAMP:20260515T155218
CREATED:20201117T084847Z
LAST-MODIFIED:20201117T084847Z
UID:27957-1611100800-1611273599@www.pharmajournalist.com
SUMMARY:Onco Cell Therapy Global
DESCRIPTION:Following the success of our first digital event in July with the likes of Carl June leading the keynote\, the Onco Cell Therapy Summit is returning in its most interactive form ever with 20+ panel conversations\, townhall meetings\, roundtable sessions and coffee break style networking. \n \nThe Global Onco Cell Therapy Summit is an online event\, 20th – 21st January 2021\, that provides a platform for information sharing to enable the discovery\, translation and commercialization of cell therapies in oncology by connecting senior representatives in pharma\, biotechs and academia. The summit will address the research\, regulatory\, logistical and technical challenges that are holding back the field. \nDelve into how thought leaders in cell therapy are addressing threats and opportunities to bring effective therapies to the market through: \n\nMeeting efficacies and safety targets as well as the scale of demands.\nDiscovering the latest advances in the journey towards effective allogeneic and solid tumor targeting therapies.\nOvercoming the challenging in scale up and automation of manufacturing\nRound table discussions on vectors and the promise of non-viral approaches.\nReimbursement strategies and their link to the latest developments in safety trials and regulatory standards\n\nWhilst bringing together the key decision makers for oncological cell therapies\, this year’s summit will have an added focus on the data releases and mergers that are driving the surge of interest in harnessing alternative cell therapies in cancer treatments. \nNew for 2020 | Pre-event sessions: \n25th Nov | Manufacturing roundtable | FREE to attend \n15th Dec | ASH Review | FREE to attend \n19th Jan | NK Day | Registrants only \nVisit the website www.oncocelltherapyglobal.com for more details and to view the full agenda. (link to https://go.kisacoresearch.com/l/678123/2020-11-16/4r1xv). Don’t forget as a reader of Pharma Journalist\, quote PJ10 for a 10% discount.
URL:https://www.pharmajournalist.com/event/onco-cell-therapy-global/
LOCATION:Virtual Event
ORGANIZER;CN="Kisaco Research":MAILTO:events@kisacoresearch.com
END:VEVENT
END:VCALENDAR